{"DataElement":{"publicId":"6813975","version":"1","preferredName":"Cervical Cancer FIGO 2018 Stage","preferredDefinition":"The staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2018.","longName":"CRVX_FIGO_2018_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6796619","version":"1","preferredName":"Cervical Neoplasm Stage","preferredDefinition":"Relating to a neck, or cervix, in any sense._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"2434808v1.0:2224086v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2434808","version":"1","preferredName":"Cervical Neoplasm","preferredDefinition":"Relating to a neck, or cervix, in any sense.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12844:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical","conceptCode":"C12844","definition":"Relating to a neck, or cervix, in any sense.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0643AECC-B6B2-298D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-30","modifiedBy":"ONEDATA","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224086","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1A4F-0A96-5494-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C4F2F14-EDF3-5587-E053-F662850AA792","latestVersionIndicator":"Yes","beginDate":"2019-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-27","modifiedBy":"TAYLORT","dateModified":"2019-07-10","changeDescription":"6-27-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6813938","version":"1","preferredName":"Cervical Cancer by FIGO 2018 Stage","preferredDefinition":"A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2018._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6813938v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6814239","version":"1","preferredName":"Stage IV Cervical Cancer FIGO 2018","longName":"6814239","preferredDefinition":"The cervical carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV). (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cervical Cancer FIGO 2018","conceptCode":"C162245","definition":"The cervical carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV). (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D443199-8624-48D6-E053-F662850A3F5B","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D443199-863D-48D6-E053-F662850A3F5B","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6814240","version":"1","preferredName":"Stage III Cervical Cancer FIGO 2018","longName":"6814240","preferredDefinition":"Cervical carcinoma that involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cervical Cancer FIGO 2018","conceptCode":"C162239","definition":"Cervical carcinoma that involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D443199-8649-48D6-E053-F662850A3F5B","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D443199-8662-48D6-E053-F662850A3F5B","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6814241","version":"1","preferredName":"Stage II Cervical Cancer FIGO 2018","longName":"6814241","preferredDefinition":"The cervical carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervical Cancer FIGO 2018","conceptCode":"C162234","definition":"The cervical carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D443199-866E-48D6-E053-F662850A3F5B","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D443199-8687-48D6-E053-F662850A3F5B","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6814242","version":"1","preferredName":"Stage I Cervical Cancer FIGO 2018","longName":"6814242","preferredDefinition":"The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded). (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cervical Cancer FIGO 2018","conceptCode":"C162226","definition":"The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded). (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D443199-8693-48D6-E053-F662850A3F5B","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D443199-86AC-48D6-E053-F662850A3F5B","beginDate":"2019-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813939","version":"1","preferredName":"Stage IVB Cervical Cancer FIGO 2018","longName":"6813939","preferredDefinition":"The cervical carcinoma has spread to distant organs. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Cervical Cancer FIGO 2018","conceptCode":"C162247","definition":"The cervical carcinoma has spread to distant organs. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EF02-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EF1B-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813940","version":"1","preferredName":"Stage IVA Cervical Cancer FIGO 2018","longName":"6813940","preferredDefinition":"The cervical carcinoma has spread to adjacent pelvic organs. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Cervical Cancer FIGO 2018","conceptCode":"C162246","definition":"The cervical carcinoma has spread to adjacent pelvic organs. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EF27-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EF40-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIIC2","valueDescription":"Stage IIIC2 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813941","version":"1","preferredName":"Stage IIIC2 Cervical Cancer FIGO 2018","longName":"6813941","preferredDefinition":"Cervical carcinoma with para-aortic lymph node metastasis. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC2 Cervical Cancer FIGO 2018","conceptCode":"C162244","definition":"Cervical carcinoma with para-aortic lymph node metastasis. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EF4C-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EF65-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIIC1","valueDescription":"Stage IIIC1 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813942","version":"1","preferredName":"Stage IIIC1 Cervical Cancer FIGO 2018","longName":"6813942","preferredDefinition":"Cervical carcinoma with pelvic lymph node metastasis only. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC1 Cervical Cancer FIGO 2018","conceptCode":"C162243","definition":"Cervical carcinoma with pelvic lymph node metastasis only. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EF71-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EF8A-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813943","version":"1","preferredName":"Stage IIIC Cervical Cancer FIGO 2018","longName":"6813943","preferredDefinition":"Cervical carcinoma with involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r and p notations). (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Cervical Cancer FIGO 2018","conceptCode":"C162242","definition":"Cervical carcinoma with involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r and p notations). (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EF96-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EFAF-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813944","version":"1","preferredName":"Stage IIIB Cervical Cancer FIGO 2018","longName":"6813944","preferredDefinition":"Cervical carcinoma with extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause). (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cervical Cancer FIGO 2018","conceptCode":"C162241","definition":"Cervical carcinoma with extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause). (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EFBB-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EFD4-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813945","version":"1","preferredName":"Stage IIIA Cervical Cancer FIGO 2018","longName":"6813945","preferredDefinition":"Cervical carcinoma that involves the lower third of the vagina, with no extension to the pelvic wall. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cervical Cancer FIGO 2018","conceptCode":"C162240","definition":"Cervical carcinoma that involves the lower third of the vagina, with no extension to the pelvic wall. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EFE0-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-EFF9-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813946","version":"1","preferredName":"Stage IIB Cervical Cancer FIGO 2018","longName":"6813946","preferredDefinition":"Cervical carcinoma with parametrial involvement but not up to the pelvic wall. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cervical Cancer FIGO 2018","conceptCode":"C162238","definition":"Cervical carcinoma with parametrial involvement but not up to the pelvic wall. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F005-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F01E-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIA2","valueDescription":"Stage IIA2 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813947","version":"1","preferredName":"Stage IIA2 Cervical Cancer FIGO 2018","longName":"6813947","preferredDefinition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, equal or more than 4 cm in greatest dimension. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2 Cervical Cancer FIGO 2018","conceptCode":"C162237","definition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, equal or more than 4 cm in greatest dimension. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F02A-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F043-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIA1","valueDescription":"Stage IIA1 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813948","version":"1","preferredName":"Stage IIA1 Cervical Cancer FIGO 2018","longName":"6813948","preferredDefinition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, less than 4 cm in greatest dimension. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1 Cervical Cancer FIGO 2018","conceptCode":"C162236","definition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, less than 4 cm in greatest dimension. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F04F-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F068-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813949","version":"1","preferredName":"Stage IIA Cervical Cancer FIGO 2018","longName":"6813949","preferredDefinition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervical Cancer FIGO 2018","conceptCode":"C162235","definition":"Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F074-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F08D-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IB3","valueDescription":"Stage IB3 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813950","version":"1","preferredName":"Stage IB3 Cervical Cancer FIGO 2018","longName":"6813950","preferredDefinition":"Invasive cervical carcinoma equal or more than 4 cm in greatest dimension. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB3 Cervical Cancer FIGO 2018","conceptCode":"C162233","definition":"Invasive cervical carcinoma equal or more than 4 cm in greatest dimension. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F099-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F0B2-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IB2","valueDescription":"Stage IB2 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813951","version":"1","preferredName":"Stage IB2 Cervical Cancer FIGO 2018","longName":"6813951","preferredDefinition":"Invasive cervical carcinoma equal or more than 2 cm and less than 4 cm in greatest dimension. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2 Cervical Cancer FIGO 2018","conceptCode":"C162232","definition":"Invasive cervical carcinoma equal or more than 2 cm and less than 4 cm in greatest dimension. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F0BE-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F0D7-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IB1","valueDescription":"Stage IB1 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813952","version":"1","preferredName":"Stage IB1 Cervical Cancer FIGO 2018","longName":"6813952","preferredDefinition":"Invasive cervical carcinoma with equal or more than 5 mm depth of stromal invasion, and less than 2 cm in greatest dimension. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1 Cervical Cancer FIGO 2018","conceptCode":"C162231","definition":"Invasive cervical carcinoma with equal or more than 5 mm depth of stromal invasion, and less than 2 cm in greatest dimension. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F0E3-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F0FC-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813953","version":"1","preferredName":"Stage IB Cervical Cancer FIGO 2018","longName":"6813953","preferredDefinition":"Invasive cervical carcinoma with measured deepest invasion equal or more than 5 mm (greater than Stage IA), lesion limited to the cervix uteri. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervical Cancer FIGO 2018","conceptCode":"C162230","definition":"Invasive cervical carcinoma with measured deepest invasion equal or more than 5 mm (greater than Stage IA), lesion limited to the cervix uteri. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F108-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F121-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IA2","valueDescription":"Stage IA2 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813954","version":"1","preferredName":"Stage IA2 Cervical Cancer FIGO 2018","longName":"6813954","preferredDefinition":"Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2 Cervical Cancer FIGO 2018","conceptCode":"C162229","definition":"Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F12D-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F146-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IA1","valueDescription":"Stage IA1 Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813955","version":"1","preferredName":"Stage IA1 Cervical Cancer FIGO 2018","longName":"6813955","preferredDefinition":"Cervical carcinoma with measured stromal invasion less than 3 mm in depth. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1 Cervical Cancer FIGO 2018","conceptCode":"C162228","definition":"Cervical carcinoma with measured stromal invasion less than 3 mm in depth. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F152-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F16B-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Cervical Cancer FIGO 2018","ValueMeaning":{"publicId":"6813956","version":"1","preferredName":"Stage IA Cervical Cancer FIGO 2018","longName":"6813956","preferredDefinition":"Invasive cervical carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion less than 5 mm. (FIGO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cervical Cancer FIGO 2018","conceptCode":"C162227","definition":"Invasive cervical carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion less than 5 mm. (FIGO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-F177-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D2BFDB5-F190-5958-E053-F662850A44D3","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6813937","version":"1","preferredName":"Cervical Cancer by FIGO Stage 2018 Stage","preferredDefinition":"A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2018.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C162225:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer by FIGO Stage 2018","conceptCode":"C162225","definition":"A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2018.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFDB5-EED7-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"ONEDATA","dateModified":"2019-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"8D2BFDB5-EEE8-5958-E053-F662850A44D3","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"TAYLORT","dateModified":"2019-07-10","changeDescription":"7-8-19 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCIP","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Princess Margaret Cancer Centre","type":"Alternate Question Text","description":"FIGO Stage 2018 Cervix Uteri","url":null,"context":"NCIP"},{"name":"FIGO stage","type":"Preferred Question Text","description":"FIGO stage","url":null,"context":"NCI Standards"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"8D2CE598-C495-2DA5-E053-F662850A442F","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-08","modifiedBy":"TAYLORT","dateModified":"2019-07-10","changeDescription":"7-8-2019 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}